Out of the Lab: Operationalizing Cell and Gene Therapy
The Outsourcing Trap: Why Pharma Needs to Reclaim Manufacturing | Hedley Rees
What was said
And we see now with Nova Holdings acquiring Catalan, that is a major event... it does exemplify the fact that you know, Novo Holdings and Novo Nordisk now have got in-house critical assets.